Search results

352 items
  1. Human rights and drug policy

    • Ernestien Jensema
    18 June 2018
    Primer

    An accessible but comprehensive primer on why TNI believes that human rights must be at the heart of any debate on drug control.

  2. “The drug market is thriving” while the Commission on Narcotic Drugs limps along

    Ann Fordham
    11 April 2018
    Article

    The admission by UN's lead agency for drugs, the UNODC,  that “the drug market is thriving” in its 2017 World Drug Report is an important one given that it is months away from 2019 – the target date by which governments committed to “significantly reduce or eliminate” the global drug market. At the recent annual gathering of the Commission on Narcotic Drugs (CND) in Vienna, this abysmal failure to claim any progress towards these  ‘drug-free’ targets was the backdrop to the latest round of tense negotiations on global drug control.

  3. Transnational Institute’s Drugs & Democracy Programme Team

    World Drug Day 2018

    26 June 2018
    Declaration

    Today, on the United Nations’ International Day Against Drug Abuse and Illicit Trafficking (26th June), governments around the world are commemorating their decades-long support of the global war on drugs. 

  4. The elegant way to end global cannabis prohibition: Inter se modification

    18 October 2018
    Multi-media

    Countries that embrace legal regulation find themselves in breach of international law. In this video, we explain a strategy to resolve those treaty tensions and to enable progressive and sustainable change at the global level.

  5. Transnational Institute’s Drugs & Democracy Programme Team

    World Drug Day 2019

    26 June 2019
    Declaration

    Today marks the United Nations’ International Day Against Drug Abuse and Illicit Trafficking. Its origin can be traced back to the institutional architecture of the global drug control system which for the last five decades has served as a mechanism that regulates, controls, or prohibits the use and distribution of more than 300 psychoactive substances.

  6. Donald Trump

    Trump to Host UN Meeting on Drug Policy: Veneer of Consensus Masks Deep Disagreement on Global Drug Policy

    John Walsh, Ann Fordham, Martin Jelsma, Hannah Hetzer
    22 September 2018
    Article

    The "Global Call to Action" document that the U.S. government is circulating—and heavily pressuring reluctant countries to sign—is explicitly “not open for negotiation.” Far from an effort at achieving mutual understanding and genuine consensus, it is an instance of heavy-handed U.S. “with us or against us” diplomacy.

  7. Canada’s next steps on cannabis and the UN Drug Treaties

    David Bewley-Taylor, Tom Blickman, Martin Jelsma, John Walsh
    03 April 2018
    Opinion

    Ever since the introduction of Bill C-45, questions have been swirling concerning Canada’s position relative to the UN drug control conventions: conventions to which Canada is a party and that, crucially, prohibit the creation of regulated markets for the recreational use of cannabis.

  8. INCB hearing on the use of cannabis for medical and non-medical purposes

    David Bewley-Taylor
    14 May 2018
    Article

    TNI's Prof. Dave Bewley-Taylor recently delivered a statement on how states can reconcile treaty obligations with democratically mandated policy shifts at the national level to a legally regulated cannabis market, with due regard for international law, and what role the International Narcotics Control Board can play in this process.

  9. Growers' voices at the Commission on Narcotic Drugs

    Sai Lone, Pedro Arenas
    24 November 2019
    Declaration

    From 16 to 18 October 2019, representatives of member states, intergovernmental organisations, and civil society attended the 6th Intersessional Meeting of the Commission on Narcotic Drugs. On 17 October 2019, representatives of coca and opium growers from Colombia and Myanmar delivered statements highlighting the situation of communities involved in the illicit cultivation of coca and opium in both countries. Below are their full statements.

  10. The WHO’s First-Ever Critical Review of Cannabis

    • John Walsh, Martin Jelsma, Tom Blickman, David Bewley-Taylor
    19 March 2019
    Policy briefing

    The World Health Organization’s (WHO) Expert Committee on Drug Dependence (ECDD or Expert Committee) released in January 2019 the outcomes of the first-ever critical review of cannabis, recommending a series of changes in the current scheduling of cannabis-related substances under the UN drug control conventions.

  11. Opium harvest in early 2019 in Pekhon Township, southern Shan State (TNI)

    A Distortion of Reality: Drugs, Conflict and the UNODC’s 2018 Myanmar Opium Survey

    Transnational Institute (TNI)
    05 March 2019
    Article

    The recently-released “Myanmar Opium Survey 2018” by the United Nations Office on Drugs and Crime (UNODC) entails specific accusations against several of the conflict actors. This commentary explains how this further distorts, rather than reflects, the complex realities in Myanmar.

  12. Video report of the UN drug debate

    Drugreporter HCLU
    08 April 2015
    Multi-media

    This March, our video advocacy team attended the 58th session of the Commission on Narcotic Drugs, the largest drug policy gathering in the world, to find out how governments and NGOs feel about the prospects of drug policy reform. We produced a series of short thematic videos, to give you an overview of the current state of political debate on the burning issues of international drug control.

  13. Canada moves closer to regulating cannabis for non-medical purposes

    Washington Office on Latin America (WOLA)
    03 May 2018
    Article

    Canada is on track to become the second country and the first G7 member to legalize and regulate cannabis for non-medical purposes (Uruguay enacted cannabis regulation in 2013).

  14. Thumbnail

    The World Drug Report 2007

    01 August 2007

    This IDPC Briefing reviews the data in the latest report from the UN Office on Drugs and Crime on the state of the global market, criticises the claims made in the report that international action is successfully controlling the market, and questions the political objectivity of the UNODC as we approach the review of the global objectives set in 1998.

  15. The World Drug Report 2007

    31 July 2007

    This IDPC Briefing reviews the data in the latest report from the UN Office on Drugs and Crime on the state of the global market, criticises the claims made in the report that international action is successfully controlling the market, and questions the political objectivity of the UNODC as we approach the review of the global objectives set in 1998.

     

  16. The 2009 World Drug Report

    30 September 2009

    The World Drug Report 2009 was the first publication of note to come from the UNODC since the High Level Segment of the 52nd session of the Commission on Narcotic Drugs.  As such, it was eagerly anticipated for not only what it would say about the trends in world drug markets, but also what it might reveal about the outlook of the senior management of the Office itself after the UNGASS review.

     

  17. Thumbnail

    Press reports: UN Drug Control

    17 November 2005
    Article

    Press coverage on UN Drug Control

  18. Global Commission on Drug Policy Report

    02 June 2011

    The global war on drugs has failed, with devastating consequences for individuals and societies around the world. Fifty years after the initiation of the UN Single Convention on Narcotic Drugs, and 40 years after President Nixon launched the US government’s war on drugs, fundamental reforms in national and global drug control policies are urgently needed.

     

  19. The UN Drug Control Debate

    • Martin Jelsma
    24 October 2005

    The 48th session of the UN Commission on Narcotic Drugs (CND), 7-11 March 2005 in Vienna, was plagued by controversy about the legitimacy of harm reduction policies. Ending in stalemate, guidance for UNODC to operate in this field remains ambiguous. In June, at the Programme Coordinating Board (PCB), a consensus was reached regarding a mandate for UNAIDS to be involved in needle exchange programmes and other harm reduction activities among injecting drug users. What options are available to clarify UNODC’s mandate in this area and more in general to achieve a breakthrough in policy dilemmas that surfaced recent years at the UN level. 

  20. International Drug Policy: Animated Report 2009

    05 March 2009

    Produced by an Oscar-winning studio for the Global Drug Policy Program of the Open Society Institute, International Drug Policy: Animated Report 2009 highlights some of the disastrous effects of drug policy in recent years and proposes solutions for a way forward.

Pages